OLIGOMETASTATIC PROSTATE CARCINOMA
Clinical trials for OLIGOMETASTATIC PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OLIGOMETASTATIC PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for OLIGOMETASTATIC PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to stall spread of prostate cancer
Disease control OngoingThis study tests whether adding the drug relugolix to standard radiation therapy can delay cancer growth in men with prostate cancer that has spread to a few other body spots. Relugolix lowers testosterone, which some cancer cells need to grow. About 194 men will receive either r…
Matched conditions: OLIGOMETASTATIC PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 09:54 UTC
-
New radioactive drug takes aim at hard-to-treat prostate cancer
Disease control OngoingThis early-phase trial tests an experimental drug called [Ac-225]-PSMA-62 in 142 men with a specific type of prostate cancer that shows up on a PSMA scan. The drug delivers a tiny dose of radiation directly to cancer cells. The main goals are to find the safest dose and to check …
Matched conditions: OLIGOMETASTATIC PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 09:53 UTC
-
New radiation approach aims to tame recurrent prostate cancer with fewer side effects
Disease control OngoingThis study tests two types of radiation therapy—proton beam and IMRT—given in shorter courses for men whose prostate cancer has come back and spread only to pelvic or abdominal lymph nodes. The goal is to see if the shorter treatment is safer and causes fewer severe side effects.…
Matched conditions: OLIGOMETASTATIC PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 09:51 UTC